
Organogenesis Investor Relations Material
Latest events

Q1 2025
Organogenesis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Organogenesis Holdings Inc
Access all reports
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of products for the advanced wound care and surgical biologics markets. The company's portfolio includes skin substitutes and other tissue-based products designed to promote healing and tissue regeneration. Organogenesis serves healthcare providers, offering solutions for the treatment of chronic and acute wounds, as well as products used in surgical and sports medicine applications. The company is headquartered in Canton, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ORGO
Country
🇺🇸 United States